Segment Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.4M | Sell |
5,576
-692
| -11% | -$149K | 0.07% | 144 |
|
|
2026
Q1 | $1.36M | Buy |
6,268
+586
| +10% | +$130K | 0.08% | 139 |
|
|
2025
Q4 | $1.3M | Sell |
5,682
-52
| -0.9% | -$11.8K | 0.08% | 139 |
|
|
2025
Q3 | $1.33M | Sell |
5,734
-126
| -2% | -$25.7K | 0.08% | 135 |
|
|
2025
Q2 | $1.09M | Buy |
5,860
+15
| +0.3% | +$2.79K | 0.07% | 154 |
|
|
2025
Q1 | $1.22M | Sell |
5,845
-200
| -3% | -$38.9K | 0.08% | 136 |
|
|
2024
Q4 | $1.07M | Sell |
6,045
-2
| -0% | -$368 | 0.07% | 143 |
|
|
2024
Q3 | $1.19M | Sell |
6,047
-8
| -0.1% | -$1.49K | 0.08% | 138 |
|
|
2024
Q2 | $1.04M | Buy |
6,055
+696
| +13% | +$115K | 0.08% | 144 |
|
|
2024
Q1 | $976K | Buy |
5,359
+146
| +3% | +$25.2K | 0.07% | 146 |
|
|
2023
Q4 | $808K | Buy |
5,213
+1,364
| +35% | +$199K | 0.07% | 145 |
|
|
2023
Q3 | $574K | Sell |
3,849
-829
| -18% | -$122K | 0.06% | 151 |
|
|
2023
Q2 | $630K | Sell |
4,678
-1,679
| -26% | -$246K | 0.06% | 138 |
|
|
2023
Q1 | $1.01M | Hold |
6,357
| – | – | 0.11% | 106 |
|
|
2022
Q4 | $1.03M | Sell |
6,357
-75
| -1% | -$11.5K | 0.12% | 105 |
|
|
2022
Q3 | $863K | Sell |
6,432
-375
| -6% | -$53.8K | 0.11% | 109 |
|
|
2022
Q2 | $1.04M | Sell |
6,807
-2,527
| -27% | -$386K | 0.13% | 100 |
|
|
2022
Q1 | $1.51M | Buy |
9,334
+106
| +1% | +$15.4K | 0.16% | 98 |
|
|
2021
Q4 | $1.25M | Buy |
9,228
+2,525
| +38% | +$298K | 0.13% | 107 |
|
|
2021
Q3 | $723K | Buy |
6,703
+25
| +0.4% | +$2.86K | 0.09% | 133 |
|
|
2021
Q2 | $752K | Buy |
6,678
+100
| +2% | +$11.3K | 0.09% | 134 |
|
|
2021
Q1 | $712K | Buy |
6,578
+78
| +1% | +$8.34K | 0.09% | 129 |
|
|
2020
Q4 | $696K | Hold |
6,500
| – | – | 0.1% | 127 |
|
|
2020
Q3 | $569K | Hold |
6,500
| – | – | 0.09% | 129 |
|
|
2020
Q2 | $638K | Sell |
6,500
-158
| -2% | -$13.9K | 0.12% | 107 |
|
|
2020
Q1 | $507K | Sell |
6,658
-1,273
| -16% | -$108K | 0.11% | 116 |
|
|
2019
Q4 | $703K | Buy |
7,931
+1,487
| +23% | +$123K | 0.12% | 116 |
|
|
2019
Q3 | $488K | Sell |
6,444
-150
| -2% | -$10.3K | 0.1% | 131 |
|
|
2019
Q2 | $480K | Hold |
6,594
| – | – | 0.1% | 127 |
|
|
2019
Q1 | $531K | Buy |
6,594
+375
| +6% | +$30.7K | 0.11% | 126 |
|
|
2018
Q4 | $573K | Sell |
6,219
-2,105
| -25% | -$185K | 0.14% | 107 |
|
|
2018
Q3 | $788K | Buy |
8,324
+9
| +0.1% | +$853 | 0.17% | 109 |
|
|
2018
Q2 | $770K | Sell |
8,315
-23
| -0.3% | -$2.25K | 0.18% | 106 |
|
|
2018
Q1 | $790K | Sell |
8,338
-119
| -1% | -$13.1K | 0.2% | 99 |
|
|
2017
Q4 | $818K | Buy |
8,457
+262
| +3% | +$24.7K | 0.2% | 105 |
|
|
2017
Q3 | $728K | Sell |
8,195
-136
| -2% | -$10.4K | 0.19% | 100 |
|
|
2017
Q2 | $604K | Buy |
8,331
+349
| +4% | +$23.5K | 0.17% | 109 |
|
|
2017
Q1 | $520K | Buy |
7,982
+14
| +0.2% | +$880 | 0.17% | 108 |
|
|
2016
Q4 | $499K | Buy |
7,968
+400
| +5% | +$24.4K | 0.18% | 104 |
|
|
2016
Q3 | $477K | Sell |
7,568
-42
| -0.6% | -$2.72K | 0.19% | 101 |
|
|
2016
Q2 | $472K | Buy |
7,610
+17
| +0.2% | +$1.04K | 0.19% | 90 |
|
|
2016
Q1 | $434K | Sell |
7,593
-30,316
| -80% | -$1.69M | 0.16% | 97 |
|
|
2015
Q4 | $2.25M | Sell |
37,909
-229
| -0.6% | -$13.2K | 0.85% | 44 |
|
|
2015
Q3 | $2.08M | Buy |
38,138
+1,435
| +4% | +$93.4K | 0.79% | 50 |
|
|
2015
Q2 | $2.47M | Hold |
36,703
| – | – | 0.86% | 46 |
|
|
2015
Q1 | $2.15M | Buy |
36,703
+4,660
| +15% | +$282K | 0.72% | 55 |
|
|
2014
Q4 | $2.1M | Sell |
32,043
-787
| -2% | -$49.6K | 0.8% | 47 |
|
|
2014
Q3 | $1.9M | Buy |
32,830
+238
| +0.7% | +$13.2K | 0.72% | 49 |
|
|
2014
Q2 | $1.84M | Buy |
32,592
+1,066
| +3% | +$55.9K | 0.71% | 45 |
|
|
2014
Q1 | $1.62M | Buy |
31,526
+2,418
| +8% | +$122K | 0.75% | 51 |
|
|
2013
Q4 | $1.54M | Buy |
29,108
+1,312
| +5% | +$64.5K | 0.76% | 47 |
|
|
2013
Q3 | $1.24M | Buy |
27,796
+1,560
| +6% | +$69.2K | 0.68% | 48 |
|
|
2013
Q2 | $1.08M | Buy |
+26,236
| New | +$1.15M | 0.65% | 49 |
|
Other funds holding ABBV
Segment Wealth Management's ABBV Position: Q2 2026 in Review
Segment Wealth Management reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $149K and leaving 5,576 shares worth $1.4M. The position accounts for 0.07% of the portfolio, ranked #144.
Segment Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.47M in Q2 2015. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Segment Wealth Management held 5,576 shares of AbbVie worth $1.4M as of Q2 2026.
- Segment Wealth Management sold 692 AbbVie shares in Q2 2026, an estimated $149K.
- AbbVie made up 0.07% of Segment Wealth Management's portfolio in Q2 2026, its #144 holding.
- Segment Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Segment Wealth Management's AbbVie position peaked at $2.47M in Q2 2015.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Segment Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.